Researchers Edge Closer to Cure for Dengue Fever

July 2, 2015
Posted in

Researchers are inching closer toward the development of a treatment and cure for dengue fever, which affects an estimated 400 million people each year.
 Caused by a mosquito-borne virus, dengue fever causes severe, flu-like symptoms, and in particularly bad cases that are caused by repeated infection, the disease can be fatal.
 In a study published in the journal Science, researchers in the U.S. and Singapore describe the discovery of a potent human antibody that neutralizes dengue type 2, an aggressive version of the virus.

Vanderbilt looking to better predict flu strains

May 15, 2015

Every year, health officials do their best to predict the flu strains that will hit the U.S. and develop a vaccine to cover them. Unfortunately, they sometimes miss their mark. Now, Vanderbilt researchers are hoping to add some precision to the process. During any given year, the flu vaccine can be anywhere from 20- to 90-percent effective  depending on how accurately health officials predict which strains are coming. That doesn't include situations like the one this year where the H1N2 strain appeared out of nowhere.

Studies Show Human Antibodies Can Fight Lethal Marburg Virus

February 26, 2015
Posted in

Researchers at Vanderbilt University, the University of Texas Medical Branch at Galveston and The Scripps Research Institute for the first time have shown how human antibodies can neutralize the Marburg virus, a close cousin to Ebola. Their findings, published this week in two papers in the journal Cell, should speed development of the first effective treatment and vaccine against these often lethal viruses, said James Crowe Jr., M.D., whose team at Vanderbilt isolated and characterized the antibodies.

Your Blood Tested Positive for Ebola. I Am Sorry.

Dr. Ada Igonoh
November 12, 2014

Once in a while, you read something that’s so compelling, you want to share it with everyone you can. Dr. Ada Igonoh’s story had that effect on me. Dr. Igonoh is a physician in Lagos, Nigeria, where she helped care for Patrick Sawyer, the patient who introduced Ebola into Nigeria in July. After coming down with the deadly virus herself, she spent two harrowing weeks getting treatment in isolation wards.

Dr. Crowe Elected to the Institute of Medicine

October 23, 2014
Posted in

October 23, 2014  -  This week, the National Academies announced the election of the Vanderbilt Vaccine Center's own Doctor Crowe to the Institute of Medicine (IOM). The now over 1900 members of the IOM serve as an advising council to the United States on health policy, practice, and research. Dr. Nancy Brown, chair and physician-in-chief of the Vanderbilt Medical Center, was inducted into the IOM alongside Dr.

Senator Alexander Meets with Crowe Lab to Learn About the Fight Against Ebola

September 24, 2014
Posted in

September 24th, 2014  -  On Wednesday, Senator Lamar Alexander visited Vanderbilt University Medical Center to meet with Dr. Crowe and his team in order to learn about the existing defenses against Ebola. Dr. Crowe and his lab conduct research which aims to develop a drug to protect individuals against the Ebola virus that has recently spread through West Africa.

Dr. Crowe to present cutting-edge research at Discovery Lecture

May 22, 2014
Posted in

Dr. Crowe will present his lecture, "Next Generation Vaccines" on Thursday, May 22, at 4 pm in 208 Light Hall as a part of Vanderbilt's Discovery Lecture series. This series seeks to respond to the requests of the Biomedical Advisory Board in presenting discussion-stimulating topics in research. Dr. Borden Lacy and Dr. Simon Mallal will also present findings that showcase Vanderbilt University's position on the cutting-edge of medical research; their lectures are respectively entitled "Structure and Function of Clostridium difficile Toxins A and B" and "Personalized Immunology."